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The  efﬁcacy  of  a  novel  topical  combination  of  ﬁpronil  8.3%  w/v,  (S)-methoprene  10%  w/v,
eprinomectin  0.4%  w/v,  and  praziquantel  8.3%  w/v (BROADLINE®,1 Merial)  against  larval  and
adult Aelurostrongylus  abstrusus  lungworms  in  cats was  assessed  in a controlled  laboratory
study.  The  study  included  48 purpose-bred,  short-haired  cats which  were  each  inoculated
with  225  infective  A.  abstrusus  larvae.  The  cats were  formed  into  eight  blocks  based  on
pre-treatment  bodyweight  and  were  then,  within  each  block,  randomly  allocated  to  one  of
six treatment  groups:  untreated  control;  treated  once  when  A.  abstrusus  were  expected  to
be  third-stage  larvae  (4 days  post  inoculation  [dpi]),  fourth-stage  larvae  (7  dpi), immature
adults  (14  dpi)  or adult  nematodes  (32 dpi),  or treated  twice,  once  when  A.  abstrusus  were
expected to be third-stage  larval  and  once  again  when  A.  abstrusus  were  expected  to be  adult
nematodes  (4  dpi  + 32 dpi).  Cats  weighing  ≥0.8–2.5  kg  received  one  0.3  mL  applicator  and
cats weighing  >2.5–7.5  kg  received  one  0.9 mL  applicator.  For  determination  of  the  efﬁcacy
of  treatments,  lungworm  larval  counts  were  established  on  faecal  samples  collected  from
all  cats  32,  39,  46, 53  and  60 dpi. At  each  occasion  from  46  dpi  on,  cats  treated  with  ﬁpronil,
(S)-methoprene,  eprinomectin  and  praziquantel  had signiﬁcantly  lower  A.  abstrusus  lar-
val counts  than  the  untreated  controls  with  percentage  reductions  of  91.6%  (cats  treated
14 dpi;  P  =  0.012),  ≥98.9%  (cats  treated  either  4 dpi,  7 dpi  or 32  dpi;  P < 0.001)  or >99.9%  (cats
treated  4  dpi  +  32  dpi;  P < 0.001)  at 60 dpi.  Thus,  the  novel  topical  combination  of ﬁpronil,
(S)-methoprene,  eprinomectin  and praziquantel  was  highly  effective  in  the  prevention  and
treatment  of A.  abstrusus  lungworm  infection  in  cats.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).∗ Corresponding author. Tel.: +49 8032 70750; fax: +49 8032 707525.
E-mail address: martin.knaus@merial.com (M.  Knaus).
1 Broadline® is a trademark of Merial; all other marks are the property
of  their respective owners.
http://dx.doi.org/10.1016/j.vetpar.2014.02.042
0304-4017/© 2014 The Authors. Published by Elsevier B.V. This is an open acce
licenses/by-nc-nd/3.0/).1. Introduction
Parasitic nematode infections of the respiratory tract of
both dogs and cats have received increasing attention by
both clinicians and parasitologists in the recent years and
prompted speciﬁc surveys on feline parasitic lungworm
infections. The metastrongyloid Aelurostrongylus abstrusus
ss article under the CC BY-NC-ND license (http://creativecommons.org/
y Parasi
i
d
e
R
e
e
q
e
o
a
2
l
1
f
r
2
p
(
o
s
l
t
A
s
s
l
t
o
i
h
n
l
b
t
2
a
a
s
(
2
a
n
(
2
c
t
c
d
d
t
1
2
2
t
m
a
i
Each cat was  inoculated orally once with approximately
225 infective third-stage larvae which were obtained from
experimentally infected Helix aspersa snails. For inocu-
lation, a recent ﬁeld isolate (as deﬁned per VICH GL  7,
Table 1
Characteristics of experimental cats used in the study of the efﬁcacy of
a  novel topical combination of ﬁpronil, (S)-methoprene, eprinomectin
and praziquantel against larval and adult stages of the cat lungworm,
Aelurostrongylus abstrusus.
Treatment groups Animal data
Age
(months)
Sexa Pre-treatment
bodyweight (kg)
Control, untreated 7–11 3 M,  5 F 2.19–4.64
Treatedb, 4 dpic,d 7–10 4 M,  4 F 2.24–4.26
Treated, 10 dpie 7–10 4 M,  4 F 2.00–4.69
Treated, 14 dpif 7–10 5 M,  3 F 2.01–4.41
Treated, 32 dpig 7–14 5 M,  3 F 2.20–4.44
Treated, 4d dpi
+ 32g dpi
7–10 3 M,  5 F 2.19–4.36
a M = male, F = female.
b Broadline® = ﬁpronil (8.3% w/v), (S)-methoprene (10% w/v), epri-
nomectin (0.4% w/v), and praziquantel (8.3% w/v); 0.3 mL, cats ≥0.8–2.5 kg
body weight; 0.9 mL,  cats >2.5–7.5 kg body weight.
c dpi = days post inoculation.
d Aelurostrongylus abstrusus expected to be third-stage larvae.
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s apparently the most prevalent pulmonary parasite of
omestic cats (reviewed by Traversa et al., 2010; Mircean
t al., 2010; Di Cesare et al., 2011; Knaus et al., 2011;
amos et al., 2012; Barutzki and Schaper, 2013; Capári
t al., 2013; Riggio et al., 2013; Spada et al., 2013; Waap
t al., 2013) while other lungworms were reported less fre-
uently – Capillaria aerophila (Mircean et al., 2010; Knaus
t al., 2011; Di Cesare et al., 2011; Mugnaini et al., 2012)
r occasionally only – Oslerus rostratus (Juste et al., 1992)
nd Troglostrongylus spp. (Jefferies et al., 2010; Brianti et al.,
012).
After the original description of A. abstrusus iso-
ated from a cat in Germany in 1890 (Mueller,
891), the global distribution of this parasite in
elines was documented through numerous case
eports and epidemiological surveys (Bowman et al.,
002).
Aelurostrongylus abstrusus resides in the lower res-
iratory tract, particularly in the bronchioli and alveoli
lung parenchyma) of felines. Female nematodes are
viparous and eggs that are laid develop into ﬁrst-
tage larvae in the alveoli and alveolar ducts of the
ungs. First-stage larvae pass through the respiratory into
he gastrointestinal tract and are shed with the faeces.
elurostrongylus abstrusus develops to the infective third-
tage larvae in a wide spectrum of terrestrial snail and
lug species which serve as intermediate hosts in the
ife cycle of this parasite. However, cats probably acquire
he parasite under natural conditions through ingestion
f prey (e.g., small mammals, birds, reptiles, or amphib-
ans) which feed on gastropods and serve as paratenic
osts. In cats, larvae penetrate the upper gastrointesti-
al tract within the ﬁrst day of infection and reach the
ungs shortly thereafter. After two more moults, females
egin to lay eggs in the fourth week following infec-
ion (Anderson, 2000; Bowman et al., 2002; Grewal et al.,
003).
Many naturally acquired A. abstrusus infections are
pparently asymptomatic or subclinical in nature. Several
uthors, however, have reported a range of respiratory
igns associated with Aelurostrongylus infections in cats
e.g., Scott, 1973; Losonsky et al., 1978; Grandi et al.,
005; Payo-Puente et al., 2005; Iannino et al., 2013),
nd necropsy and sophisticated intravital diagnostic tech-
iques revealed pathological changes of varying degree
e.g., Mackenzie, 1960; Stockdale, 1970; Payo-Puente et al.,
005; Dennler et al., 2013). Studies have shown that
ats presenting signs of respiratory disease tested posi-
ive more frequently for A. abstrusus than cats of unknown
linical status (Barutzki and Schaper, 2011, 2013). Con-
itions compromising the immune system of cats are
iscussed to play a role in the clinical manifestation of
he infection and may  complicate diagnosis (Mackenzie,
960; Hamilton, 1963; Schuster et al., 1999; Tüzer et al.,
002; Grandi et al., 2005; Traversa et al., 2008; Dürr,
009).
The study reported here was conducted to evaluate
he efﬁcacy of a novel topical combination of ﬁpronil, (S)-
ethoprene, eprinomectin and praziquantel against larvalnd adult stages of A. abstrusus in cats using an induced
nfection design.tology 202 (2014) 64–68 65
2. Material and methods
The design of the study was  in accordance with the
International Cooperation on Harmonisation of Techni-
cal Requirements for Registration of Veterinary Medicinal
Products (VICH) – GL7, “Efﬁcacy of Anthelmintics: General
Requirements” (Vercruysse et al., 2001) and GL20 “Efﬁcacy
of Anthelmintics: Speciﬁc Recommendations for Felines”
(Vercruysse et al., 2002), and the “World Association for the
Advancement of Veterinary Parasitology (WAAVP) guide-
lines for evaluating the efﬁcacy of anthelmintics for dogs
and cats” (Jacobs et al., 1994). Recovery of nematodes
associated with the lungs of cats has been considered
impracticable and hence, as recommended by WAAVP,
monitoring of faecal lungworm larval counts in treated and
untreated animals was used to assess the efﬁcacy against A.
abstrusus (Jacobs et al., 1994). The study was conducted in
compliance with VICH GL9, entitled Good Clinical Practice
and in compliance with local animal welfare legislation
and was  approved by an Independent Animal Care and
Use Committee. All personnel involved in collecting efﬁ-
cacy data were blinded to the treatment assignment of the
animals.
2.1. Experimental animals and inoculation
The study included 48 purpose-bred short-haired cats.
Cats weighed 2.0–4.7 kg prior to treatment and were
approximately 7–14 months old (Table 1). The animals
were housed individually throughout the study under iden-
tical conditions. All cats were negative for A. abstrusus
larvae prior to inoculation as conﬁrmed by examination of
faeces subjected to the Baermann-Wetzel larval migration
technique.Aelurostrongylus abstrusus expected to be fourth-stage larvae.
f Aelurostrongylus abstrusus expected to be immature adults.
g Aelurostrongylus abstrusus expected to be adults.
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Vercruysse et al., 2001) from a naturally infected cat from
Albania was used. The isolate was passed through H. aspersa
and cats for approximately four years in the laboratory
before being used in this study.
2.2. Study design
The study utilized a randomized block design based
on pre-treatment bodyweight. Cats were ranked based on
decreasing bodyweight and blocks of six cats each were
formed. Within blocks, cats were allocated randomly to one
of six groups: untreated (control); treated once when A.
abstrusus were expected to be third-stage larvae (4 days
post inoculation, dpi); treated once when A. abstrusus were
expected to be fourth-stage larvae (7 dpi); treated once
when A. abstrusus were expected to be immature adults
(14 dpi); treated once when A. abstrusus were expected to
be adults (32 dpi); treated twice, once when A. abstrusus
were expected to be third-stage larvae and once again
when they were expected to be adults (4 dpi + 32 dpi).
Treatment times were selected based on the developmen-
tal cycle of A. abstrusus in the cat (reviewed by Anderson,
2000).
The treatment, ﬁpronil 8.3% w/v, (S)-methoprene 10%
w/v, eprinomectin 0.4% w/v, praziquantel 8.3% w/v,
(Broadline®, Merial), was administered once topically
directly on the skin in the midline of the neck between the
base of the skull and the shoulder blades in a single spot.
Cats weighing ≥0.8–2.5 kg received one 0.3 mL  applicator,
and cats of >2.5–7.5 kg body weight received one 0.9 mL
applicator. The dosage corresponded to the label dose of
the novel combination formulation. All cats were observed
hourly for four hours post-treatment and thereafter once
daily until end of the study for health problems or adverse
events.
2.3. Faecal examinations
Faecal samples were collected from all cats on 32 dpi,
and weekly thereafter until 60 dpi and examined for A.
abstrusus larvae (Fig. 1) using the quantitative Baermann-
Wetzel migration technique utilizing individual 10 g faecal
samples.
2.4. Data analysis
Aelurostrongylus abstrusus larval counts were trans-
formed to the natural logarithm of (count +1) for
calculation of geometric means for each treatment group
and time point. Efﬁcacy for each treated group and time
point were determined by calculating the percent efﬁcacy
as 100[(C − T)/C], where C was the geometric mean among
untreated controls and T was the geometric mean among
the treated animals. The log-counts of the treated group
was compared to the log-counts of the untreated con-
trol group. In addition, pairwise comparisons among the
treated groups were conducted at each study day. Both
sets of comparisons used an F-test adjusted for the alloca-
tion blocks used to randomize the animals to the treatment
groups. The mixed procedure in SAS® Version 9.1.3 was
used for the analysis, with the treatment groups listed asFigure 1. Aelurostrongylus abstrusus larva 1 extracted from a Baermann.
©Merial.
a ﬁxed effect, and the allocation blocks listed as a ran-
dom effect. The comparisons of the treated group with the
untreated controls were tested using a two-sided at the sig-
niﬁcance level  ˛ = 0.05. For pairwise comparisons among
the treated groups, to adjust for the a posteriori multiple
comparisons, the Bonferroni adjustment was  used: within
each time point, two treated groups were signiﬁcantly dif-
ferent if P < 0.05/10 = 0.005.
3. Results
No adverse experiences or other health problems were
observed after treatment application or throughout the
course of the study, indicating that the treatment was well
accepted. All cats in this study were considered as nor-
mal  based on daily clinical observations; no clinical signs
indicating respiratory distress were observed in any of the
cats.
The results of the study as regards A. abstrusus lar-
val counts and percentage efﬁcacy are summarized in
Table 2. The study was  considered valid in the sense of
the adequacy-of-infection criterion per VICH GL7 and VICH
GL20 as at least seven cats in the control group shed A.
abstrusus larvae throughout 39–60 dpi. No A. abstrusus lar-
vae were recovered from the faeces of the cats collected
32 dpi.
Faecal examination at 39 dpi revealed A. abstrusus larvae
in the faeces of seven untreated control cats and the cats
treated on 32 dpi. As female A. abstrusus were observed to
begin laying of eggs as early as 25 dpi (Stockdale, 1970),
this ﬁnding indicates that the larvae recovered from the
cats’ faeces developed from eggs produced already before
32 dpi.
Aelurostrongylus abstrusus larval counts from 46 dpi,
53 dpi and 60 dpi demonstrated ≥98.9%, ≥99.3%, ≥91.6%
and ≥99.6% efﬁcacy (P ≤ 0.012) of a single treatment with
Broadline® spot on against third-stage larvae, fourth-
stage larvae, immature adults or adults of A. abstrusus,
respectively; two  consecutive treatments one month apart
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Table  2
Larval counts and therapeutic efﬁcacy of the topical combination product against different developmental stages of Aelurostrongylus abstrusus in cats.
Geometric meana A. abstrusus larval counts per gram of faeces (range) Efﬁcacyb,
60 dpi
39 dpi 46 dpi 53 dpi 60 dpi
Control, untreated 33.8a (0–384) 309.1a (0.2–1440) 356.4a (0–2640) 253.1a (0–5200) –
Treatedc, 4 dpid,e 0b (0) 0.6b (0–4.4) 2.1b (0–37.5) 2.8b (0–98) 98.9%
Treated, 10 dpif 0b (0) 0.9b (0–10.3) 2.1b (0–23.7) 1.8b (0–62) 99.3%
Treated, 14 dpig 0b (0) 0.4b (0–1.9) 4.8b (0.3–198) 21.1b (0.1–564) 91.6%
Treated, 32 dpih 44.0a (1.1–1690) 0.8b (0–8.3) 1.0b (0–3.2) 0.9b (0–12.7) 99.6%
Treated, 4 dpie + 32 dpih 0b (0) <0.1b (0–0.1) <0.1b (0–0.3) <0.1b (0–0.2) >99.9%
a Based on transformation to ln [count +1]).
b Efﬁcacy = 100 [(geometric mean untreated (control) group – geometric mean Topical FMEP group)/geometric mean untreated (control) group].
c Broadline® = Topical ﬁpronil (8.3% w/v), (S)-methoprene (10% w/v), eprinomectin (0.4% w/v), and praziquantel (8.3% w/v); 0.3 mL,  cats ≥0.8–2.5 kg body
weight; 0.9 mL,  cats >2.5–7.5 kg body weight.
d dpi = days post inoculation.
e Aelurostrongylus abstrusus expected to be third-stage larvae.
f Aelurostrongylus abstrusus expected to be fourth-stage larvae.
g Aelurostrongylus abstrusus expected to be immature adults.
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a,  b) Two-sided comparison of larval counts of each Topical FMEP grou
igniﬁcantly different (p < 0.001, but p = 0.012 for Topical FMEP, 14 dpi vs.
4 dpi + 32 dpi) resulted in a >99.9% reduction of larval shed-
ing throughout (P < 0.001). For each time point, there
as no statistically signiﬁcant difference of the lungworm
arval counts among the groups treated apart from one
ccasion: Aelurostrongylus abstrusus larval counts of the
ats treated 14 dpi were higher than those of the cats which
eceived two treatments one month apart (4 dpi + 32 dpi;
 = 0.002) at 60 dpi.
. Discussion
This is the ﬁrst study demonstrating a high efﬁcacy of
he novel topical combination formulation containing the
vermectin eprinomectin against larval and adult stages
f A. abstrusus in cats. To compensate for irregular larval
elease and shedding and the potential limited sensitiv-
ty of the Baermann-Wetzel technique, faecal examinations
n this study were conducted in weekly intervals for three
eeks following ﬁrst isolation of A. abstrusus larvae 39 dpi,
hus allowing for a better understanding on the sus-
ainability of the treatment with the novel combination
ormulation. The results of this study with time points of
reatment selected based on the developmental cycle of
. abstrusus (reviewed by Anderson, 2000) indicate that
he administration of the combination product to infected
ats signiﬁcantly affected all parasitic stages in the deﬁni-
ive host and prevented the establishment of A. abstrusus
o a very high level. Efﬁcacy against pre-patent develop-
ental stages is an important feature of anthelmintics as
his property contributes to a more sustainable control
f aelurostrongylosis in cats, and it can be assumed that
he pulmonary changes, which are progressing during the
nfection A. abstrusus (cf. Stockdale, 1970; Dennler et al.,
013), will be markedly reduced.
This is the ﬁrst reported controlled laboratory study in
hich a macrocyclic lactone demonstrated efﬁcacy against
ll parasitic stages of A. abstrusus in the cat. Macrocyclic
actone compounds have been used as anthelmintics in
ets for several years and were shown to provide a high
fﬁcacy against infections of various nematode parasiteshe Control group per time point: ﬁgures with no letter in common are
 at 60 dpi).
(reviewed by Nolan and Lok, 2012). In cats, the use of
various macrocyclic lactones administered by different
routes and at different doses against naturally acquired
A. abstrusus infections were reported previously in sev-
eral case reports with inconsistent treatment efﬁcacies
(Blagburn et al., 1987; Kirkpatrick and Megella, 1987; Tüzer
et al., 2002; Reinhardt et al., 2004; Grandi et al., 2005)
or studies conducted under ﬁeld conditions lacking neg-
ative control animals (Brianti et al., 2008; Traversa et al.,
2009a,b; Iannino et al., 2013). As seen previously in ﬁeld
studies (Brianti et al., 2008; Iannino et al., 2013), a complete
reduction of A. abstrusus larval shedding following a single
treatment with macrocyclic lactone products is typically
not achieved, and repeated treatments along with repeated
faecal examinations to monitor the treatment effect may
be necessary. Monthly use of Broadline® is expected to
provide a very high level of efﬁcacy, as demonstrated by
the results in cats treated on post-infection days 4 and 32.
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